BiopharmaTrend.com

Insilico Medicine

Insilico Medicine

Private company
INSILICO MEDICINE
Hong Kong

A company dedicated to finding novel solutions for aging and age-related diseases using advances in genomics and big data analysis.

Our mission statement and our pledge to our investors, friends and families: Through excellence in knowledge management, machine learning and bioinformatics, relentless pursuit for new drug, omics and clinical outcomes data, development of reliable in silico drug screening methods, novel validation approaches and strong international partnerships in personalized medicine we strive to find real working solutions to cure and prevent age-related diseases and aging itself.

This mission will be achieved within within the regulatory frameworks as well as the legal and ethical boundaries and by working with the outstanding scientists, academic and medical institutions and pharmaceutical companies of impeccable credibility.

Our goals are:

- to become the first and the largest drug discovery company in aging and age-related diseases;
- to become the first company to fully implement the concept of personalized science, where medicine is developed, tested and validated for individual patients in a safe high-throughput environment


Founded
2014
Status
Private company
Geography
Hong Kong based
Funding
$51.300 M
Patents
7
Research papers
75

Products

Chemistry42

Chemistry42 is an automated machine learning platform for drug design capable of finding novel lead-like molecules in a week

Read more

Pandomics

A roadmap to successful disease research and target identification strategies requires considerable resources spent on search, collection and interpretation of …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page